Intrinsiqq
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc.

DCOY

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$2M
EPS$201.77
P/E0.00
P/FCF–
EV/EBITDA0.36
FCF Yield–
Div. Yield–
Net Debt/FCF–
Decoy Therapeutics Inc. intrinsic value
52-Week Range
$0.83$2.31

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$17M

▼ -124.5% YoY

Op. Margin

–

ROIC

-287.66%

▼ -137.5pp YoY

Cash Flow & Balance Sheet

FCF (FY)

-$5M

▼ -19.4% YoY

Op. Cash Flow (TTM)

-$9M

▼ -6.7% YoY

Net Debt

-$8M

Net Cash Position

Cash & Equiv.

$8M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with DCOY

CompareIntrinsic value
SCPXScorpius Holdings Inc.
$0.00+0.00%10
CPMDCannapharmaRx Inc.
$0.00+0.00%24
SGMTSagimet Biosciences Inc.
$9.12-5.20%10
ORMPOramed Pharmaceuticals Inc.
$3.57-3.25%35
DNTHDianthus Therapeutics Inc.
$84.55-0.33%10
CYCNCyclerion Therapeutics Inc.
$35.45+6.55%40
PLRXPliant Therapeutics Inc.
$0.60-4.02%10
MCRBSeres Therapeutics, Inc.
$1.24-6.77%0

Held by ETFs

DCOY is in 1 US ETF. The largest of them, with DCOY's weight in each:

Decoy Therapeutics (DCOY) in three numbers

Quality score
20/100
Best check: net debt, -$8M. Weakest: return on capital, -287.7%.
Quality
Dividend
None
Last paid in 2019, nothing since.
Dividends
P/E
0.00
From the last twelve months of earnings.
Financials

Questions about Decoy Therapeutics

Is Decoy Therapeutics (DCOY) overvalued?

Decoy Therapeutics trades at 0.00 times earnings. Intrinsiqq's fair value calculator has no opening value for DCOY, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.

Is Decoy Therapeutics a high-quality business?

Decoy Therapeutics scores 20 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is net debt at -$8M, and its weakest is return on capital at -287.7%. The Quality tab shows every check against its target.

Does Decoy Therapeutics (DCOY) pay a dividend?

No. Decoy Therapeutics (DCOY) does not currently pay a dividend. The last payment in our data was in 2019, and nothing has been paid since. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 11 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in DCOY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing DCOY

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.